Close Menu

NEW YORK – Caprion Biosciences and HistoGeneX said today that they are combining their businesses to form a new company focused on immune monitoring and biomarker development.

The new firm, whose name was not disclosed, will provide immune monitoring and biomarker services to biopharma companies, offering tools for preclinical work through to late-stage clinical trials and companion diagnostic development.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.